PSEN1 loss-of-function variants do not cause early-onset Alzheimer's disease
Auteurs : A. Farinas, A. Pena-Tauber, T. J. Hohman, A. G. Contreras, T. D. Jensen, Y. Le Guen, M. D. Greicius
Résumé scientifique
PSEN1 variants are the most common cause of familial early-onset Alzheimer's disease (EOAD), but it is debated whether they act through a loss- or gain-of-function. Following a recent report of a duo with EOAD carrying a predicted loss-of-function (LoF) stop-gain variant (p.K109*) in PSEN1, we sought to determine whether PSEN1 LoF variants, as a class, cause EOAD. We identified 45 carriers of PSEN1 LoF variants predicted to trigger nonsense-mediated decay in the Alzheimer's Disease Sequencing Project, UK Biobank, and BioVU databases. None of these carriers had a recorded case of early-onset dementia, and 17 were older than 65 years at last follow-up with no dementia or AD reported. Re-analysis of the reported AD-associated variant p.K109* revealed a cryptic splice site predicted to produce an in-frame deletion of 5 amino acids (p.K109_L113del). These results suggest that PSEN1 variants must produce an altered PSEN1 protein product to cause EOAD, while true null LoF PSEN1 alleles do not cause EOAD.
Les articles autour de lui, par date et par proximité
Plus haut, c’est plus proche de cet article ; à gauche, c’est plus ancien. Les traits relient les articles proches entre eux : les groupes de traits sont des sous-thèmes. Sélectionnez un point pour voir pourquoi il est là. Retour au résumé de cet article
Les articles autour de celui-ci
Classés selon la proximité de leur titre et de leur résumé avec ceux de cet article. Sélectionnez-en pour les lire ensemble.
Les articles les plus proches
-
Presenilin 1 Mutations Converge on Aβ42/Aβ40 Elevation via Distinct MechanismsIsabel Bestard-Lorigados, Keenan Sterling, Li-Wei Li et al. · 2026 · MedComm · cité 1 fois · Pas encore résumé
Résumé scientifique
Mutations in Presenilin 1 (PS1) are the most common genetic cause of familial Alzheimer's disease (AD). However, the exact mechanisms by which these mutations alter amyloid precursor protein (APP) processing and drive amyloid β (Aβ) production remain unclear. In this study, five PS1 mutations (M146V, G384A, C410Y, Y115H, and the Notch‐sparing mutation ΔS169) were transfected into neuroblastoma cells lacking endogenous PS1/PS2 expression and human embryonic kidney cells stably overexpressing either wild‐type APP or the APP Swedish mutation. We investigated the effects of these mutations on APP processing, Aβ42/Aβ40 ratio, cytotoxicity, BACE1 expression, and PS1 endoproteolysis. Our results de…
-
Motor manifestations in PSEN1-Related early-onset Alzheimer’s disease: a case series and systematic reviewM. Genz, Ingrid Lorena da Silva Gomes, F. Junqueira et al. · 2026 · ANPAbstract_CBN26 · Pas encore résumé
Résumé scientifique
Background: Autosomal dominant early-onset Alzheimer’s disease (EOAD) is a distinct subset of dementia, often affecting individuals during their working age. It is most frequently caused by pathogenic variants in PSEN1, accounting for the majority of genetically confirmed cases worldwide. Although typically characterized by amnestic cognitive decline, increasing evidence highlights substantial phenotypic variability among PSEN1 carriers, suggesting manifestations extend beyond the cognitive domain. Motor features, including pyramidal signs, dystonia and parkinsonism, have been reported in different stages of the disease, but are not routinely integrated into the recognized clinical spectrum.…
-
Effect of high-risk SORL1 variants on clinical presentation in symptomatic Alzheimer’s diseaseM. D. de Waal, Janna I. R. Dijkstra, L. Vermunt et al. · 2026 · Alzheimer's Research & Therapy · Pas encore résumé
Résumé scientifique
Rare, high-risk variants in SORL1 are established genetic contributors to Alzheimer’s disease (AD), but their impact on clinical presentation remains uncharacterized. This study investigates the effect of rare high-risk SORL1 variant ( SORL1 hi ) carriers on the clinical presentation, cognitive decline and time from diagnosis to death in symptomatic AD. Patients with a biomarker-confirmed diagnosis of symptomatic AD and available genetic information ( n = 1546, age at diagnosis 64.3 ± 7, 52% female, 69% APOE ε4 carriers) were included from the Amsterdam Dementia Cohort. SORL1 hi carriers were identified per established criteria, and wild-type (WT) carriers ( n = 1511) served as controls. Bas…
-
Tau A152T risk variant drives distinct cell type transcriptional signatures in AD and PSPMeredith T. Lilley, Ying-Xue Ren, Disha M. Soni et al. · 2026 · Acta Neuropathologica · Pas encore résumé
Résumé scientifique
The A152T point mutation is a rare genetic variant in the tau gene (MAPT) that is linked to risk of Alzheimer’s disease (AD) and frontotemporal dementia spectrum disorders, including progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). To uncover mechanisms through which the A152T variant contributes to risk of tauopathy, we performed single-nucleus RNA sequencing (snRNA-seq) on postmortem brain tissue collected from A152T carriers and pathology-matched non-carriers with either AD or PSP, along with age-matched controls. These efforts revealed that despite similar cell type composition across groups, A152T carriers exhibited distinct cell type-specific transcriptional ch…
-
Pregnancy History and Loss of Normal PSEN2 Function Impact Female Late-Life Cognitive Processing, Inhibitory Signaling, and GliosisJen-Nie I. Fang, Leanne Lehmann, K. Prater et al. · 2026 · bioRxiv · preprint, non relu par les pairs · Pas encore résumé
-
Data from the ROPAD study corroborate an association between ITSN1 loss-of-function variants and Parkinson’s diseaseC. Ganoza, A. Westenberger, J. J. Paul et al. · 2026 · npj Parkinson's Disease · Pas encore résumé
Résumé scientifique
We read with interest the recent studies by Skuladottir and colleagues and Coganandcolleagues,whichreportanovelassociationbetweenmonoallelic loss-of-function(LoF)variantsinthe ITSN1 gene and risk for Parkinson ’ s disease (PD) 1,2 . The fi rst study observed that heterozygous LoF variants in ITSN1 confer a large risk for developing PD in analyses combining the deCODE, UK Biobank, and Accelerating Medicines Partnership Parkinson ’ s Disease (AMP-PD) datasets 1 . The second study identi fi ed fi ve PD patients from three families who harbored distinct heterozygous frameshift ITSN1 variants and reported their clinical phenotype 2 . Yet another recent study reported similar results in an analysis o…
-
Genomic Landscape of Early-Onset and Familial Latin American Parkinson’s PatientsE. Waldo, H. M. Chaparro-Solano, M. Isayan et al. · 2026 · medRxiv · preprint, non relu par les pairs · Pas encore résumé
Résumé scientifique
Background Parkinson's disease (PD), the most common neurodegenerative movement disorder, is commonly thought of as an aging and sporadic disease; however, 5-14% of individuals experience disease onset before the age of 50 years (early-onset PD; EOPD) and about 20% have a positive family history. In the case of both EOPD and people with a family history of PD, evidence suggests higher rates of a disease-causing genetic contribution. Objectives Our goal was to perform a variant screening of seven PD-related genes and 21 genes associated with related parkinsonian disorders to identify pathogenic/likely pathogenic variants and variants of uncertain significance within EOPD and family-history-po…
-
Alzheimer's disease genetics converges on microglial and neuronal dysregulation.E. Uffelmann, D. Wightman, S. Bahrami et al. · 2026 · Nature · Pas encore résumé
Résumé scientifique
Alzheimer's disease (AD) is the most common cause of dementia, with global case numbers projected to reach 153 million in 20501. AD is highly heritable, with twin-based heritability estimates of 60-80%2. Although 1,200 causal loci are predicted to exist for AD3, approximately 80 loci have been associated with AD in two recent studies4,5. Low single-nucleotide polymorphism (SNP)-based heritability estimates have prompted the suggestion that little further common-variant risk remains to be found6. Here we analysed data from 109,479 cases, 74,141 proxy cases, 2,131,799 controls and 499,708 proxy controls from diverse ancestries, identifying 118 loci in a multi-ancestry analysis and 9 additional…
Aller plus loin
Comment ces articles sont-ils trouvés ?
Nous comparons le titre et le résumé de cet article avec ceux de tous les articles résumés sur ce site, et avec les articles que Semantic Scholar recommande, ceux qu’il cite et ceux qui le citent (pour un article très cité, ses citations les plus récentes et, depuis OpenAlex, les plus citées). Parmi les travaux antérieurs et les suites, les articles qui s’utilisent en profondeur, une méthode qu’il utilise et les suites très citées remontent un peu. Les niveaux (très proche, proche, apparenté) viennent de la similarité des textes, pas d’un jugement de qualité ; * signale un article sans résumé, comparé par son titre. La phrase sous un article est écrite par une IA à partir des deux résumés : vérifiez-la dans les articles. Un article jugé hors sujet par trois lecteurs quitte la liste.
Mis à jour le 16 novembre 2026.